Keyword: United Kingdom

Visa denials for researchers trying to attend scientific meetings in the U.K. could ramp up after Brexit, the Wellcome Trust warned.

Pro-Remain politicians saw the reiteration of an old position as evidence that the split from the U.K. will decimate life science research.  

Scientists have demonstrated how mutations in cell proteins known as “splicing factors” can cause the eye disease retinitis pigmentosa.

IQVIA and Genomics England plan to link clinical results with deidentified genomics data to generate evidence for personalized medicine.

Recardio halts clinical trials in the U.K. of a new heart drug due to concerns about Brexit.

The British biotech sector enjoyed a big third quarter, with more than £460 million in VC cash flowing into the bank accounts of U.K. companies.

Three cancer charities will pour over $39 million into six U.K. and European research projects, to provide for a post-Brexit collaboration model.

Despite their promise, antibody-drug conjugates have been tough to bring to market, but a U.K. biotech wants to change that.

CMR Surgical unveiled its modular robotic surgery platform for minimally invasive procedures after raising $100 million earlier this summer.

AstraZeneca’s anifrolumab for lupus has missed the target in the first of two ongoing phase 3 trials, putting its future in doubt.